Prevention of antiinflammatory drug-induced gastric lesions in rats by Abbott-29590.
D000700:Analgesics / Q000008:administration & dosage*; D000818:Animals; D001241:Aspirin / Q000009:adverse effects / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects / Q000473:pathology; D005756:Gastritis / Q000139:chemically induced / Q000517:prevention & control*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D007213:Indomethacin / Q000009:adverse effects / Q000037:antagonists & inhibitors; D010653:Phenylbutazone / Q000009:adverse effects / Q000037:antagonists & inhibitors; D011292:Premedication; D011725:Pyridines / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D051381:Rats; D013843:Thiazines / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D013997:Time Factors
D000700:Analgesics; D011725:Pyridines; D013843:Thiazines; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin